Celleron Therapeutics
Abingdon, Oxfordshire, United Kingdom
About Celleron Therapeutics
Celleron Therapeutics An innovative oncology healthcare company The future of cancer therapy lies in the ability to match patients to treatments they will respond favourably to. Celleron has developed biomarkers using epigenetic techniques that match drugs to responsive disease. Their portfolio of technologies can be used to develop a new class of mechanism-based cancer drugs. Drugs that will improve the success rates of treatment, reduce the side effects in patients and deliver more cost effective healthcare.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: M&A
- Last round: Series Unknown (Feb 2017)
- Website: cellerontherapeutics.com
- Phone: 4407766255216
Industries & Categories
Biotechnology, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/celleron-therapeutics-2500717 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.